<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE315nnn/GSE315794/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Methylation profiling</omics_type><species>Homo sapiens</species><gds_type>Methylation profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315794</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Non-ablative fractional laser 1940nm treatment series modulates epigenetic pathways and signs of skin aging: a split face investigation</name><description>Skin aging is driven by cumulative environmental damage and epigenetic dysregulation, yet it is unclear whether energy-based rejuvenation therapies can durably remodel the cutaneous methylome. To address this, we conducted a split-face, paired longitudinal study in 22 adults treated with a 1940-nm non-ablative fractional laser (NAFL). Epidermal samples were collected by tape stripping from treated and contralateral control sites at baseline, immediately after the first treatment, and at 1, 3, and 6 months. Enzymatic methyl-sequencing profiled ~3.8 million CpGs per sample; clinical endpoints included pigmentation, texture, and global aesthetic scores. No significant differentially methylated regions (DMRs) were detected immediately post-treatment, but 635 DMRs emerged from 1 month after the final session, expanding through 3 months and stabilizing by 6 months. These loci were enriched for pathways involved in epidermal differentiation, collagen organization, wound response, and stem-cell maintenance, and showed selective resetting at Polycomb-regulated and WNT-signaling genes. NAFL reversed age-associated methylation change at >83% of age-linked CpGs and engaged gene sets previously implicated in molecular rejuvenation. Treatment also induced transient, treatment-specific DMRs related to immune and stress responses. Epigenetic remodeling paralleled significant clinical improvements, indicating that 1940-nm NAFL drives durable molecular rejuvenation rather than transient repair.</description><dates><publication>2026/07/08</publication></dates><accession>GSE315794</accession><cross_references><GSM>GSM9437495</GSM><GSM>GSM9437496</GSM><GSM>GSM9437497</GSM><GSM>GSM9437530</GSM><GSM>GSM9437531</GSM><GSM>GSM9437498</GSM><GSM>GSM9437499</GSM><GSM>GSM9437510</GSM><GSM>GSM9437532</GSM><GSM>GSM9437511</GSM><GSM>GSM9437533</GSM><GSM>GSM9437534</GSM><GSM>GSM9437512</GSM><GSM>GSM9437513</GSM><GSM>GSM9437535</GSM><GSM>GSM9437514</GSM><GSM>GSM9437536</GSM><GSM>GSM9437537</GSM><GSM>GSM9437515</GSM><GSM>GSM9437516</GSM><GSM>GSM9437517</GSM><GSM>GSM9437518</GSM><GSM>GSM9437519</GSM><GSM>GSM9437493</GSM><GSM>GSM9437494</GSM><GSM>GSM9437520</GSM><GSM>GSM9437521</GSM><GSM>GSM9437500</GSM><GSM>GSM9437522</GSM><GSM>GSM9437523</GSM><GSM>GSM9437501</GSM><GSM>GSM9437502</GSM><GSM>GSM9437524</GSM><GSM>GSM9437503</GSM><GSM>GSM9437525</GSM><GSM>GSM9437504</GSM><GSM>GSM9437526</GSM><GSM>GSM9437505</GSM><GSM>GSM9437527</GSM><GSM>GSM9437528</GSM><GSM>GSM9437506</GSM><GSM>GSM9437507</GSM><GSM>GSM9437529</GSM><GSM>GSM9437508</GSM><GSM>GSM9437509</GSM><GPL>34281</GPL><GSE>315794</GSE><taxon>Homo sapiens</taxon><PMID>[42380171]</PMID></cross_references></HashMap>